The scourge of LGBTQ criminalisation moving across African countries – and its impact on HIV
New US HIV agreements leave civil society and key populations on the sidelines
PEPFAR cuts close key population services and accelerate decline in children's HIV treatment
Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing
Top 5 stories on threats to the global HIV response from CROI 2026
Top 5 stories on the HIV response in Africa from CROI 2026
PrEP uptake was already low – and then came the cuts
Counting the costs of global HIV funding disruptions
The war on science: resisting and rebuilding at a crucial juncture
